I understand. I guess I just have a hard time understanding what drugs for pediatrics are being denied to Canadians right now. I'm on the Windsor-Detroit border. If we're looking at people having to modify their own medications, as opposed to a pharmacist, and we're being denied that with Ontario's market economy, which is much more robust than those of most U.S. states, it would seem that this economic argument isn't always valid.
It would seem that perhaps there are other things that might be barriers. Maybe it's packaging or some other type of regulatory burden. I don't know. Especially given the fact that we've done a number of different initiatives since I've been here, everything from lowering corporate taxes.... We've been pushing, and I know that for this committee in particular, it's the SR and ED tax credit system, which is very difficult even to this day. It's getting a little better, but it's been a nightmare for many.
It would just seem that it may be very much a harsh thing, which is that Canadians are dividing their medications and so forth for pediatrics because companies just can't make a buck here. Is that what's happening? Is that what you're saying?